CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Peyer James 10% owner | Sale | −24,524 | $20.00 | $490K | 130,618 |
| 2026-06-01 | Peyer James 10% owner | Sale | −476 | $21.14 | $10K | 130,142 |
| 2025-12-09 | Peyer James 10% owner | Sale | −2,666 | $7.95 | $21K | 155,588 |
| 2025-12-09 | Peyer James 10% owner | Option exercise | +395 | $6.40 | $3K | 155,983 |
| 2025-12-09 | Peyer James 10% owner | Sale | −395 | $8.04 | $3K | 155,588 |
| 2025-12-09 | Peyer James 10% owner | Sale | −446 | $7.92 | $4K | 155,142 |
| 2025-12-09 | Peyer James 10% owner | Option exercise · Stock Option (Right to Buy) | −395 | 0 | ||
| 2025-12-08 | Peyer James 10% owner | Sale | −3,105 | $8.59 | $27K | 158,254 |
| 2025-12-05 | Peyer James 10% owner | Sale | −14,508 | $11.40 | $165K | 163,146 |
| 2025-12-05 | Peyer James 10% owner | Sale | −1,745 | $12.29 | $21K | 161,401 |
| 2025-12-05 | Peyer James 10% owner | Sale | −42 | $13.16 | $553 | 161,359 |
| 2025-12-04 | Peyer James 10% owner | Sale | −5,000 | $9.06 | $45K | 177,654 |
| 2025-05-21 | Peyer James Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2024-06-11 | Peyer James Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2023-07-31 | Peyer James Director | Returned to the company | −1,587,302 | $1.26 | $2.0M | 3,653,120 |
| 2023-07-10 | Peyer James Director | Grant or award | +4,466 | 5,240,422 | ||
| 2023-07-10 | Peyer James Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2022-06-10 | Peyer James Director | Grant or award | +4,466 | 5,235,956 | ||
| 2022-06-10 | Peyer James Director | Grant or award · Stock Option (right to buy) | +14,550 | 14,550 | ||
| 2022-06-10 | Peyer James Director | Grant or award | +4,466 | 5,235,954 |
Page 1 of 5 · 88 trades